ARE vs COLL · P/E 100, $13.19B cap vs P/E 17, rev $181.9M
Alexandria Real Estate Equities Inc (ARE) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Alexandria Real Estate Equities Inc (ARE) is a reit - office company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
ARE does not have a complete income-statement cache yet.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
ARE currently screens at market cap $13.19B and trailing P/E 100.4. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the ARE and COLL stock pages for the full models.
Not investment advice.